Publicacións en colaboración con investigadores/as de Universidad Autónoma de Madrid (36)

2023

  1. Circulating extracellular vesicles promote recovery in a preclinical model of intracerebral hemorrhage

    Molecular Therapy - Nucleic Acids, Vol. 32, pp. 247-262

  2. Protein content of blood-derived extracellular vesicles: An approach to the pathophysiology of cerebral hemorrhage

    Frontiers in Cellular Neuroscience, Vol. 16

  3. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology

    Reumatologia Clinica, Vol. 19, Núm. 2, pp. 74-81

2021

  1. EAACI Biologicals Guidelines—Recommendations for severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 14-44

  2. Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas

    Clinical Endocrinology, Vol. 94, Núm. 5, pp. 811-819

2020

  1. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057

  2. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042

  3. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068

  4. Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country

    BMC Rheumatology, Vol. 4, Núm. 1

2019

  1. Sex and Cardiovascular Involvement in Inflammatory Joint Diseases

    Clinical Reviews in Allergy and Immunology, Vol. 56, Núm. 3, pp. 278-292

2018

  1. Inflammatory arthritis and heart disease

    Current Pharmaceutical Design, Vol. 24, Núm. 3, pp. 262-280

  2. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: A network approach

    International Journal of COPD, Vol. 13, pp. 591-601

2017

  1. Asthma-COPD overlap is not a homogeneous disorder: Further supporting data

    Respiratory Research

  2. Quality indicators of asthma care derived from the spanish guidelines for asthma management (GEMA 4.0): A multidisciplinary team report

    Journal of Investigational Allergology and Clinical Immunology

2016

  1. Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial

    Journal of Neuro-Oncology, Vol. 127, Núm. 3, pp. 569-579

  2. Validation of the international metastatic renal-cell carcinoma database consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: The Spanish oncologic genitourinary group (SOGUG) SPAZO study

    Annals of Oncology, Vol. 27, Núm. 4, pp. 706-711

2014

  1. Endoscopic submucosal dissection

    Endoscopy, Vol. 46, Núm. 4, pp. 361-370

2013

  1. SMAD3 rs17228212 Gene Polymorphism Is Associated with Reduced Risk to Cerebrovascular Accidents and Subclinical Atherosclerosis in Anti-CCP Negative Spanish Rheumatoid Arthritis Patients

    PLoS ONE, Vol. 8, Núm. 10

2012

  1. Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis

    Scandinavian Journal of Rheumatology, Vol. 41, Núm. 5, pp. 350-353

  2. Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis

    Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279